Skip to content

Viking Therapeutics VKTX Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.23B+19.0%
Amgen logo
AmgenAMGN
$12.76B+12.0%
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$579K+1,058%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$4.9M-65.4%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$61M-2.2%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$4.04B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DepositsAssetsNoncurrent.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's other non-current assets?
Viking Therapeutics (VKTX) reported other non-current assets of $33K in Q1 2026.
How has Viking Therapeutics's other non-current assets changed year-over-year?
Viking Therapeutics's other non-current assets decreased by 28.3% year-over-year, from $46K to $33K.
What is the long-term trend for Viking Therapeutics's other non-current assets?
Over 5 years (2020 to 2025), Viking Therapeutics's other non-current assets has grown at a 9.7% compound annual growth rate (CAGR), from $29K to $46K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.